打破模具:针对环境过敏原的过敏原免疫治疗的非传统方法
Rashi Ramchandani1,2, Rachel Lucyshyn3,4, Sophia Linton5,6
1Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Immunotherapy
|October 9, 2024
概括
非传统的过敏原免疫疗法为过敏性疾病的传统方法提供了更安全,更快的替代方案. 需要进一步的研究来标准化这些有前途的治疗方法,以便在更广泛的临床应用中使用.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 免疫疗法研究 免疫疗法研究
- 环境过敏原 环境过敏原
背景情况:
- 过敏原免疫疗法 (AIT) 改变了过敏性疾病的进展.
- 传统的皮下AIT是有效的,但很长时间,可能会引起不良反应.
- 非传统的AIT方法提供了潜在的提高方便性,安全性和有效性.
研究的目的:
- 综合审查各种非传统免疫疗法对环境过敏原的安全性,疗效和性能.
- 将非传统的AIT方法与传统的皮下免疫疗法进行比较.
- 确定未来研究和标准化的领域.
主要方法:
- 对非传统免疫疗法方法的审查,包括语言下,局部鼻腔,淋巴内急性,超急性,过敏性,微生物和抗IgE疗法.
- 检查治疗方案,患者的坚持和不良事件概况.
- 评估辅助疗法,如益生菌和单克隆抗体 (例如,奥马利祖马布).
主要成果:
- 非传统免疫疗法在克服传统皮下AIT的局限性方面表现有前途.
- 内淋巴和急性免疫疗法方法提供更短的治疗时间,改善患者的便利性.
- 与益生菌或奥马利祖马布同时使用可能会提高AIT的疗效和安全性.
结论:
- 非传统的免疫疗法为传统的AIT提供了有希望的替代方案.
- 进一步的大规模,长期研究对于标准化方案,剂量和验证长期影响至关重要.
- 在临床广泛采用之前,标准化结果测量对于比较非传统的AIT方法至关重要.
相关概念视频
02:06Allergic Reactions
27.3K
Overview
27.3K
01:27Allergic Drug Reactions
817
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
817
01:30Hypersensitivities
536
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
536
00:42Cross-reactivity
31.0K
Overview
31.0K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
241
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
241
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K